The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artemisinin Market Research Report 2025
Synopsis
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
The global Artemisinin market was valued at US$ 62 million in 2023 and is anticipated to reach US$ 225.3 million by 2030, witnessing a CAGR of 20.0% during the forecast period 2024-2030.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
This report aims to provide a comprehensive presentation of the global market for Artemisinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin.
Report Scope
The Artemisinin market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
Segment by Type
Extraction From Artemisia Annua
Semisynthetic Artemisinin
Segment by Application
Antimalarial Injections
Antimalarial Tablets
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Artemisinin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Artemisinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
The global Artemisinin market was valued at US$ 62 million in 2023 and is anticipated to reach US$ 225.3 million by 2030, witnessing a CAGR of 20.0% during the forecast period 2024-2030.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
This report aims to provide a comprehensive presentation of the global market for Artemisinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin.
Report Scope
The Artemisinin market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
Segment by Type
Extraction From Artemisia Annua
Semisynthetic Artemisinin
Segment by Application
Antimalarial Injections
Antimalarial Tablets
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Artemisinin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Artemisinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Artemisinin Market Overview
1.1 Product Definition
1.2 Artemisinin Segment by Type
1.2.1 Global Artemisinin Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Extraction From Artemisia Annua
1.2.3 Semisynthetic Artemisinin
1.3 Artemisinin Segment by Application
1.3.1 Global Artemisinin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Antimalarial Injections
1.3.3 Antimalarial Tablets
1.4 Global Market Growth Prospects
1.4.1 Global Artemisinin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Artemisinin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Artemisinin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Artemisinin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Artemisinin Production Market Share by Manufacturers (2019-2024)
2.2 Global Artemisinin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Artemisinin, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Artemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Artemisinin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Artemisinin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Artemisinin, Product Offered and Application
2.8 Global Key Manufacturers of Artemisinin, Date of Enter into This Industry
2.9 Artemisinin Market Competitive Situation and Trends
2.9.1 Artemisinin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Artemisinin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Artemisinin Production by Region
3.1 Global Artemisinin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Artemisinin Production Value by Region (2019-2030)
3.2.1 Global Artemisinin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Artemisinin by Region (2025-2030)
3.3 Global Artemisinin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Artemisinin Production by Region (2019-2030)
3.4.1 Global Artemisinin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Artemisinin by Region (2025-2030)
3.5 Global Artemisinin Market Price Analysis by Region (2019-2024)
3.6 Global Artemisinin Production and Value, Year-over-Year Growth
3.6.1 North America Artemisinin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Artemisinin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Artemisinin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Artemisinin Production Value Estimates and Forecasts (2019-2030)
4 Artemisinin Consumption by Region
4.1 Global Artemisinin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Artemisinin Consumption by Region (2019-2030)
4.2.1 Global Artemisinin Consumption by Region (2019-2024)
4.2.2 Global Artemisinin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Artemisinin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Artemisinin Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Artemisinin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Artemisinin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Artemisinin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Artemisinin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Artemisinin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Artemisinin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Artemisinin Production by Type (2019-2030)
5.1.1 Global Artemisinin Production by Type (2019-2024)
5.1.2 Global Artemisinin Production by Type (2025-2030)
5.1.3 Global Artemisinin Production Market Share by Type (2019-2030)
5.2 Global Artemisinin Production Value by Type (2019-2030)
5.2.1 Global Artemisinin Production Value by Type (2019-2024)
5.2.2 Global Artemisinin Production Value by Type (2025-2030)
5.2.3 Global Artemisinin Production Value Market Share by Type (2019-2030)
5.3 Global Artemisinin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Artemisinin Production by Application (2019-2030)
6.1.1 Global Artemisinin Production by Application (2019-2024)
6.1.2 Global Artemisinin Production by Application (2025-2030)
6.1.3 Global Artemisinin Production Market Share by Application (2019-2030)
6.2 Global Artemisinin Production Value by Application (2019-2030)
6.2.1 Global Artemisinin Production Value by Application (2019-2024)
6.2.2 Global Artemisinin Production Value by Application (2025-2030)
6.2.3 Global Artemisinin Production Value Market Share by Application (2019-2030)
6.3 Global Artemisinin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Sanofi
7.1.1 Sanofi Artemisinin Corporation Information
7.1.2 Sanofi Artemisinin Product Portfolio
7.1.3 Sanofi Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Main Business and Markets Served
7.1.5 Sanofi Recent Developments/Updates
7.2 KPC Pharmaceuticals
7.2.1 KPC Pharmaceuticals Artemisinin Corporation Information
7.2.2 KPC Pharmaceuticals Artemisinin Product Portfolio
7.2.3 KPC Pharmaceuticals Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 KPC Pharmaceuticals Main Business and Markets Served
7.2.5 KPC Pharmaceuticals Recent Developments/Updates
7.3 Kerui nanhai
7.3.1 Kerui nanhai Artemisinin Corporation Information
7.3.2 Kerui nanhai Artemisinin Product Portfolio
7.3.3 Kerui nanhai Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Kerui nanhai Main Business and Markets Served
7.3.5 Kerui nanhai Recent Developments/Updates
7.4 Guangxi xiancaotang
7.4.1 Guangxi xiancaotang Artemisinin Corporation Information
7.4.2 Guangxi xiancaotang Artemisinin Product Portfolio
7.4.3 Guangxi xiancaotang Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Guangxi xiancaotang Main Business and Markets Served
7.4.5 Guangxi xiancaotang Recent Developments/Updates
7.5 Guilin Pharmaceutical
7.5.1 Guilin Pharmaceutical Artemisinin Corporation Information
7.5.2 Guilin Pharmaceutical Artemisinin Product Portfolio
7.5.3 Guilin Pharmaceutical Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Guilin Pharmaceutical Main Business and Markets Served
7.5.5 Guilin Pharmaceutical Recent Developments/Updates
7.6 Natural Bio-engineering
7.6.1 Natural Bio-engineering Artemisinin Corporation Information
7.6.2 Natural Bio-engineering Artemisinin Product Portfolio
7.6.3 Natural Bio-engineering Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Natural Bio-engineering Main Business and Markets Served
7.6.5 Natural Bio-engineering Recent Developments/Updates
7.7 BIONEXX
7.7.1 BIONEXX Artemisinin Corporation Information
7.7.2 BIONEXX Artemisinin Product Portfolio
7.7.3 BIONEXX Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 BIONEXX Main Business and Markets Served
7.7.5 BIONEXX Recent Developments/Updates
7.8 CAT KHANH
7.8.1 CAT KHANH Artemisinin Corporation Information
7.8.2 CAT KHANH Artemisinin Product Portfolio
7.8.3 CAT KHANH Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 CAT KHANH Main Business and Markets Served
7.7.5 CAT KHANH Recent Developments/Updates
7.9 BEEPZ
7.9.1 BEEPZ Artemisinin Corporation Information
7.9.2 BEEPZ Artemisinin Product Portfolio
7.9.3 BEEPZ Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.9.4 BEEPZ Main Business and Markets Served
7.9.5 BEEPZ Recent Developments/Updates
7.10 Novanat Bioresource
7.10.1 Novanat Bioresource Artemisinin Corporation Information
7.10.2 Novanat Bioresource Artemisinin Product Portfolio
7.10.3 Novanat Bioresource Artemisinin Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Novanat Bioresource Main Business and Markets Served
7.10.5 Novanat Bioresource Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Artemisinin Industry Chain Analysis
8.2 Artemisinin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Artemisinin Production Mode & Process
8.4 Artemisinin Sales and Marketing
8.4.1 Artemisinin Sales Channels
8.4.2 Artemisinin Distributors
8.5 Artemisinin Customers
9 Artemisinin Market Dynamics
9.1 Artemisinin Industry Trends
9.2 Artemisinin Market Drivers
9.3 Artemisinin Market Challenges
9.4 Artemisinin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
